The Journal of Pain
Volume 10, Issue 6 , Pages 594-600 , June 2009

Tools for Identifying Cancer Pain of Predominantly Neuropathic Origin and Opioid Responsiveness in Cancer Patients

  • Sebastiano Mercadante

      Affiliations

    • Pain Relief and Palliative Care Unit, La Maddalena Cancer Center, Palermo, Italy
    • Department of Anesthesiology, Intensive care and Emergency, and Palliative Medicine, University of Palermo, Palermo, Italy
    • Corresponding Author InformationAddress reprint requests to Dr. Sebastiano Mercadante, Pain Relief and Palliative Care Unit, La Maddalena Cancer Center, Via San Lorenzo 312, 90146 Palermo, Italy.
    • ,
  • Vittorio Gebbia

      Affiliations

    • Department of Oncology, La Maddalena Cancer Center, Palermo, Italy
    • ,
  • Fabrizio David

      Affiliations

    • Pain Relief and Palliative Care Unit, La Maddalena Cancer Center, Palermo, Italy
    • ,
  • Federica Aielli

      Affiliations

    • Department of Oncology, La Maddalena Cancer Center, Palermo, Italy
    • ,
  • Lucilla Verna

      Affiliations

    • Department of Oncology, La Maddalena Cancer Center, Palermo, Italy
    • ,
  • Alessandra Casuccio

      Affiliations

    • Department of Clinical Neuroscience, University of Palermo, Palermo, Italy
    • ,
  • Giampiero Porzio

      Affiliations

    • Department of Oncology, La Maddalena Cancer Center, Palermo, Italy
    • ,
  • Salvatore Mangione

      Affiliations

    • Department of Anesthesiology, Intensive care and Emergency, and Palliative Medicine, University of Palermo, Palermo, Italy
    • ,
  • Patrizia Ferrera

      Affiliations

    • Pain Relief and Palliative Care Unit, La Maddalena Cancer Center, Palermo, Italy

Received 5 August 2008 ,Revised 9 October 2008 ,Accepted 1 December 2008.

References 

  1. Attal N, Bouhassira D. Can pain be more or less neuropathic?. Pain. 2004;110:510–511
  2. Backonja MM, Krause S. Neuropathic pain questionnaire – short form. Clin J Pain. 2003;19:305–316
  3. Bennett M. The LANSS pain scale: The Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147–157
  4. Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research. J Pain. 2005;6:149–158
  5. Bennett MI, Smith BH, Torrance N, Lee AJ. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain. 2006;122:289–294
  6. Bennett MI, Attal N, Backonja MM, Baron R, Bouhassira D, Freynhagen R, et al. Using screening tools to identify neuropathic pain. Pain. 2007;127:199–203
  7. Bennett MI, Bouhassira D. Epidemiology of neuropathic pain: Can we use the screening tools?. Pain. 2007;132:12–13
  8. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004;108:248–257
  9. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29–36
  10. Bruera E, MacMillan D, Hanson J, MacDonald RN. The Edmonton staging system for cancer pain: Preliminary report. Pain. 1989;37:203–210
  11. Caraceni A, Mendoza TR, Mencaglia E, Baratella C, Edwards K, Forjaz MJ, et al. A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain. 1996;65:87–92
  12. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. Pain. 1999;82:263–274
  13. Davis MP. What is new in neuropathic pain?. Support Care Cancer. 2007;15:363–372
  14. De Benedittis G, Massei R, Nobili R, Pieri A. The Italian Pain Questionnaire. Pain. 1988;33:53–62
  15. Devor M. Neuropathic pain: What do we do with all these theories?. Acta Anaesthesiol Scand. 2001;45:1121–1127
  16. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: An evidence-based proposal. Pain. 2005;118:289–305
  17. Finnerup NB, Jensen TS. Mechanisms of disease: Mechanism-based classification of neuropathic pain—a critical analysis. Nat Clin Pract Neurol. 2006;2:107–115
  18. Galer B, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: The neuropathic pain scale. Neurology. 1997;48:332–338
  19. Grond S, Radbruch L, Meuser T, Sabatowsky R, Loick G, Lehmann KA. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain. 1999;79:5–20
  20. Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. Clin J Pain. 2003;19:306–334
  21. Jensen TS, Gottrup H, Sindrup S, Bach FW. The clinical picture of neuropathic pain. Eur J Pharmacol. 2001;429:1–11
  22. Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain. 2003;102:1–8
  23. Mao J. Translational pain research: Bridging the gap between basic and clinical research. Pain. 2002;97:183–187
  24. Mercadante S, Fulfaro F, Casuccio A, Barresi L. Investigation of an opioid response categorization in advanced cancer patients. J Pain Symptom Manage. 1999;18:347–352
  25. Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. Part 1: Clinical considerations. J Pain Symptom Manage. 2001;21:144–150
  26. Mercadante S, Ferrera P, Villari P, Casuccio A. Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol. 2005;23:5229–5334
  27. Mercadante S, Bruera E. Opioid switching. A systematic and critical review. 2006;32:304–315
  28. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: New hypothesies derived from studies of opioid infusions. Pain. 1990;43:273–286
  29. Potter J, Higginson IJ, Scadding JW, Quigley C. Identifying neuropathic pain in patients with head and neck cancer: Use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale. J R Soc Med. 2003;96:379–383
  30. Rasmussen PV, Sindrup SH, Jensen TS, Bach FW. Symptoms and signs in patients with suspected neuropathic pain. Pain. 2004;110:461–469
  31. Rasmussen PV, Sindrup SH, Jensen TS, Bach FW. Therapeutic outcome in neuropathic pain: Relationship to evidence of nervous system lesion. Eur J Neurology. 2004;11:545–553
  32. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain. 1999;83:389–400
  33. Stute P, Soukup J, Menzel M, Sabatowski R, Grond S. Analysis and treatment of different types of neuropathic cancer pain. J Pain Symptom Manage. 2003;26:1123–1131
  34. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrowsky JO, Griffin JW, et al. Neuropathic pain. Redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–1635

PII: S1526-5900(08)00932-2

doi: 10.1016/j.jpain.2008.12.002

The Journal of Pain
Volume 10, Issue 6 , Pages 594-600 , June 2009

Article Tools

* Image Usage & Resolution